Cell Death and Disease · 2015 · 46 citations · 28 references
MedicineMolecular BiologyOncologyGene ExpressionMetabolismMolecular OncologyCancer Cell SignalingCancer MetabolismGlioblastomaMetabolic ReprogrammingMetabolic Reprogramming In CancerDirected MutagenesisFarnesyl Diphosphate SynthaseGlioblastoma MetabolismGlioblastoma Molecular PathwaysMevalonate PathwayPromotersTumor Cell MetabolismTumor Metabolism
The mevalonate (MVA) pathway is an important metabolic pathway implicated in multiple aspects of tumorigenesis. In this study, we provided evidence that p53 induces the expression of a group of enzymes of the MVA pathway including 3'-hydroxy-3'-methylglutaryl-coenzyme A reductase, MVA kinase, farnesyl diphosphate synthase and farnesyl diphosphate farnesyl transferase 1, in the human glioblastoma multiforme cell line, U343 cells, and in normal human astrocytes, NHAs. Genetic and pharmacologic perturbation of p53 directly influences the expression of these genes. Furthermore, p53 is recruited to the gene promoters in designated p53-responsive elements, thereby increasing their transcription. Such effect was abolished by site-directed mutagenesis in the p53-responsive element of promoter of the genes. These findings highlight another aspect of p53 functions unrelated to tumor suppression and suggest p53 as a novel regulator of the MVA pathway providing insight into the role of this pathway in cancer progression.
28
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
PubMed · 1997 · 66.6K citations
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
Suzanne J. Baker, Sanford D. Markowitz, Eric R. Fearon et al. · Science · 1990 · 1.8K citations
The IARC TP53 database: New online mutation analysis and recommendations to users
Magali Olivier, Rosalind A. Eeles, Monica Hollstein et al. · Human Mutation · 2002 · 1.3K citations